Reviva Pharmaceuticals News

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(18.5%),Vedanta Partners, LLC(15.9%), etc.

May 31 21:34 ET

424B5: Prospectus

May 29 13:21 ET

8-K: Current report

May 29 07:38 ET

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 17 16:34 ET

8-K: Current report

May 15 08:15 ET

10-Q: Quarterly report

May 14 08:14 ET

8-K: Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 14 08:14 ET

Reviva Pharmaceuticals | 8-K: Current report

Apr 15 17:05 ET

Reviva Pharmaceuticals | 10-K: Annual report

Apr 15 08:23 ET

Reviva Pharmaceuticals | 8-K: Current report

Apr 15 08:23 ET

Reviva Pharmaceuticals | 8-K: Current report

Apr 15 07:48 ET

Reviva Pharmaceuticals | NT 10-K: Others

Apr 2 08:04 ET

Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(10.2%)

Feb 16 16:37 ET

Reviva Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%), etc.

Feb 14 16:08 ET

Reviva Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)

Feb 14 15:57 ET

Reviva Pharmaceuticals | EFFECT: Others

Feb 14 06:09 ET

Reviva Pharmaceuticals | 424B4: Prospectus

Feb 13 18:11 ET

Reviva Pharmaceuticals | CORRESP: CORRESP

Feb 9 22:22 ET

Reviva Pharmaceuticals | UPLOAD: Others

Feb 9 22:17 ET

Reviva Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Feb 2 16:43 ET